AKBA On Other Exchanges
Symbol
Exchange
AKBA is not on other exchanges.

Executive Profile*

John P. Butler MBA

CEO, President & Director,Akebia Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 35 board members in 3 different organizations across 6 different industries.

See Board Relationships
55$3,471,072
As of Fiscal Year 2018

Background*

Mr. John P. Butler, MBA, has been the Chief Executive Officer and President of Akebia Therapeutics, Inc. since September 2013. Mr. Butler served as Chief Executive Officer of Inspiration Biopharmaceuticals, Inc. from October 11, 2011 to April 2013. He served as the President of Personalized Genetic Health at Genzyme Corporation since May 2010. He served as Senior Vice President and President of Cardiometabolic & Renal at Genzyme Corporation. He served as President of ...

Read Full Background

\

Corporate Headquarters*

245 First Street
Suite 1400
Cambridge, Massachusetts 02142

United States

Phone: 617-871-2098
Fax: 617-871-2099

Board Members Memberships*

2013-Present
CEO, President & Director
2018-Present
Chairperson of the Board
2018-Present
Director

Education*

BA
Manhattan College
MBA
Baruch College

Other Affiliations*

Annual Compensation*

Salary$594,720
Total Annual Compensation$594,720

Stock Options*

Restricted Stock Awards$1,271,270
All Other Compensation$2,000
Exercisable Options990,517
Exercisable Options Value$1,452,220
Total Value of Options$1,452,220
Total Number of Options990,517

Total Compensation*

Total Annual Cash Compensation$957,080
Total Calculated Compensation$3,471,072
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William K. Heiden CEO, President & Director
AMAG Pharmaceuticals, Inc.
$1.7M
Stuart Paul President, CEO & Director
Rockwell Medical, Inc.
$484.6K
Compensation as of Fiscal Year 2018.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AKEBIA THERAPEUTICS INC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.